Kefei Hu

634 total citations
22 papers, 483 citations indexed

About

Kefei Hu is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Kefei Hu has authored 22 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Kefei Hu's work include Respiratory viral infections research (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Immune Cell Function and Interaction (3 papers). Kefei Hu is often cited by papers focused on Respiratory viral infections research (7 papers), Viral gastroenteritis research and epidemiology (6 papers) and Immune Cell Function and Interaction (3 papers). Kefei Hu collaborates with scholars based in Sweden, China and United Kingdom. Kefei Hu's co-authors include Brør Morein, Izzeldin A. Abusugra, Gunilla Blomqvist, Margaret Chen, Claes Örvell, Peter Liljeström, Björn Rozell, Geraldine Taylor, Sara Hägglund and Jean‐François Valarcher and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Advanced Drug Delivery Reviews.

In The Last Decade

Kefei Hu

22 papers receiving 457 citations

Peers

Kefei Hu

IMMUN

EPIDE

MICRO

Jun‐ichi Maeyama Japan

Tatiane Furtado de Carvalho Brazil

Eriko Chiba Japan

Nanda de Groot Netherlands

Tamara Gull United States

Vanessa Bastos Pereira Brazil

Sandrine Melo France

Deivys Leandro Portuondo Brazil

Paola Petrucci Italy

Ivonne Ceballos‐Olvera Mexico

Jun‐ichi Maeyama Japan

Kefei Hu

372 ×2.2

IMMUN

210 ×1.3

EPIDE

149 ×1.2

220 ×1.9

75 ×1.4

MICRO

Citations per year, relative to Kefei Hu Kefei Hu (= 1×) peers Jun‐ichi Maeyama

Countries citing papers authored by Kefei Hu

Since Specialization

Citations

This map shows the geographic impact of Kefei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefei Hu more than expected).

Fields of papers citing papers by Kefei Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefei Hu. The network helps show where Kefei Hu may publish in the future.

Co-authorship network of co-authors of Kefei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Kefei Hu. A scholar is included among the top collaborators of Kefei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefei Hu. Kefei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qianwei, et al.. (2024). GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis. Discover Oncology. 15(1). 8–8. 12 indexed citations

Li, Qian, et al.. (2017). Effects of Brucine on the OPG/RANKL/RANK Signaling Pathway in MDA‐MB‐231 and MC3T3‐E1 Cell Coculture System. Evidence-based Complementary and Alternative Medicine. 2017(1). 1693643–1693643. 9 indexed citations

Hu, Kefei, et al.. (2016). MR enterography for the diagnosis of symptomatic Meckel diverticulum in pediatric patients. Zhonghua fangshexian yixue zazhi. 50(8). 620–624. 2 indexed citations

Hägglund, Sara, Kefei Hu, Didier Chevret, et al.. (2014). Characterization of an Experimental Vaccine for Bovine Respiratory Syncytial Virus. Clinical and Vaccine Immunology. 21(7). 997–1004. 8 indexed citations

Hu, Kefei, et al.. (2013). The nanoparticulateQuillajasaponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells. Leukemia & lymphoma. 55(7). 1618–1624. 1 indexed citations

Hassan, Saadia, et al.. (2013). The Nanoparticulate Quillaja Saponin BBE is selectively active towards renal cell carcinoma.. PubMed. 33(1). 143–51. 12 indexed citations

Hu, Kefei, et al.. (2011). Analysis of 1-deoxynojirimycin component correlation between medicinal parasitic loranthus from loranthaceae and their mulberry host trees. Journal of Medicinal Plants Research. 5(17). 4326–4331. 9 indexed citations

Hägglund, Sara, Kefei Hu, Jenna Anderson, et al.. (2011). Bovine respiratory syncytial virus ISCOMs—Immunity, protection and safety in young conventional calves. Vaccine. 29(47). 8719–8730. 27 indexed citations

Hu, Kefei, et al.. (2010). Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index. SHILAP Revista de lepidopterología. 4 indexed citations

10.

Morein, Brør, Gunilla Blomqvist, & Kefei Hu. (2007). Immune Responsiveness in the Neonatal Period. Journal of Comparative Pathology. 137. S27–S31. 79 indexed citations

11.

Hu, Kefei, Matthias Regner, Claire‐Anne Siegrist, et al.. (2004). The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containingQuillajasaponin components QH-A, QH-C and ISCOPREP^TM703. FEMS Immunology & Medical Microbiology. 43(2). 269–276. 18 indexed citations

12.

Regner, Matthias, Fiona J. Culley, Kefei Hu, et al.. (2004). Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection. Microbes and Infection. 6(7). 666–675. 11 indexed citations

13.

Morein, Brør, Kefei Hu, & Izzeldin A. Abusugra. (2004). Current status and potential application of ISCOMs in veterinary medicine. Advanced Drug Delivery Reviews. 56(10). 1367–1382. 105 indexed citations

14.

Hägglund, Sara, Kefei Hu, Lars Erik Larsen, et al.. (2004). Bovine respiratory syncytial virus ISCOMs—protection in the presence of maternal antibodies. Vaccine. 23(5). 646–655. 46 indexed citations

15.

Chen, Margaret, Kefei Hu, Björn Rozell, et al.. (2002). Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus. The Journal of Immunology. 169(6). 3208–3216. 56 indexed citations

16.

Hu, Kefei, Margaret Chen, Izzeldin A. Abusugra, Federica Monaco, & Brør Morein. (2001). Different respiratory syncytial virus andQuillajasaponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profiles. FEMS Immunology & Medical Microbiology. 31(2). 105–112. 3 indexed citations

17.

Morein, Brør, et al.. (1999). ISCOM: A Delivery System for Neonates and for Mucosal Administration. PubMed. 41. 405–413. 15 indexed citations

18.

Hu, Kefei, et al.. (1999). Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions. Vaccine. 17(20-21). 2690–2701. 14 indexed citations

19.

Hu, Kefei, et al.. (1999). Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes. Medical Microbiology and Immunology. 187(4). 191–198. 26 indexed citations

20.

Hu, Kefei, Brør Morein, & M. Mérza. (1998). Using Distilled Water for the Extraction of Mucosal Antibodies and the Subsequent Application in RSV Neutralization Test. Journal of Immunoassay. 19(2-3). 209–222. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact